98 results in Exploration of Musculoskeletal Diseases
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
Biologics and biosimilars in musculoskeletal diseases: addressing regulatory inconsistencies and clinical uncertainty
Lauren N. McGrath ... Steven R. Feldman
Published: July 21, 2025 Explor Musculoskeletal Dis. 2025;3:100798
62 7 0
Open Access Review
Risk factors of neoplastic disease in patients with systemic rheumatic disorders
Eugeniusz J. Kucharz
Published: July 16, 2025 Explor Musculoskeletal Dis. 2025;3:100797
127 8 0
Open Access Correction
Correction: The ‘FebBenz’ approach for severe difficult-to-treat gout
Enrique Calvo-Aranda ... Marta Novella-Navarro
Published: July 07, 2025 Explor Musculoskeletal Dis. 2025;3:100796
140 5 0
Open Access Review
A survey of the composition, safety, efficacy and regulation of non-autologous biologic treatments in human musculoskeletal pathologies
Theodore Sand
Published: June 25, 2025 Explor Musculoskeletal Dis. 2025;3:100795
This article belongs to the special issue Innovation in Orthopedics
309 10 0
Open Access Systematic Review
Quality approaches and standards of 3D printing in orthopedic and traumatological settings: a systematic review
Tanja Neussl ... Johannes Dominikus Pallua
Published: June 16, 2025 Explor Musculoskeletal Dis. 2025;3:100794
This article belongs to the special issue Innovation in Orthopedics
624 17 0
Open Access Original Article
The ‘FebBenz’ approach for severe difficult-to-treat gout
Enrique Calvo-Aranda ... Marta Novella-Navarro
Published: May 22, 2025 Explor Musculoskeletal Dis. 2025;3:100793
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
564 22 0
Open Access Review
Management of gout in advanced renal disease
John S. Richards ... Mohan Ramkumar
Published: May 07, 2025 Explor Musculoskeletal Dis. 2025;3:100791
This article belongs to the special issue Evaluation and Outcomes in the Management of Gout
1344 12 0
Open Access Perspective
Can fracture non-union be predicted using deep learning?
Ali Yüce ... Abdülhamit Misir
Published: April 08, 2025 Explor Musculoskeletal Dis. 2025;3:100790
This article belongs to the special issue Innovation in Orthopedics
711 14 0
Open Access Original Article
The prevalence and risk factors of gouty arthritis among fishermen in the Niger Delta region of Nigeria
Gogo James Owo ... Enyohwo Dennis Kpomah
Published: March 25, 2025 Explor Musculoskeletal Dis. 2025;3:100789
768 11 0
Open Access Review
Urate lowering therapy in primary care: rheum for improvement
Emilie Schurenberg ... Kenneth G. Saag
Published: March 25, 2025 Explor Musculoskeletal Dis. 2025;3:100788
This article belongs to the special issue Pharmacological and Non-Pharmacological Management of Gout
1187 10 0
Open Access Commentary
Highly effective treatment options for rheumatoid arthritis afforded by the availability of biosimilars
Leticia A. Shea, Jamshaid S. Ahmed
Published: March 03, 2025 Explor Musculoskeletal Dis. 2025;3:100787
1498 17 0
Open Access Commentary
Re-conceptualizing structural damage in chronic calcium pyrophosphate crystal inflammatory arthritis through ultrasonography: a pictorial essay
Janeth Yinh ... Ali Guermazi
Published: February 24, 2025 Explor Musculoskeletal Dis. 2025;3:100786
This article belongs to the special issue Multifaceted Imaging in Rheumatic and Musculoskeletal Diseases
972 18 0
Open Access Perspective
Perspective on clinical and imaging tools for early identification of temporomandibular joint involvement in juvenile idiopathic arthritis
Silvia Magni-Manzoni
Published: February 11, 2025 Explor Musculoskeletal Dis. 2025;3:100785
This article belongs to the special issue Multifaceted Imaging in Rheumatic and Musculoskeletal Diseases
1244 10 0
Open Access Short Communication
Transition from reference adalimumab to biosimilar SB5 in patients with rheumatoid arthritis: sub-analysis of Spanish patients in the PROPER study
Fernando Pérez-Ruiz ... Eugenio Chamizo Carmona
Published: February 10, 2025 Explor Musculoskeletal Dis. 2025;3:100784
1298 26 0
Open Access Original Article
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study
Fanny Alcira Reyes Neira ... Andrea Yukie Shimabuco
Published: February 10, 2025 Explor Musculoskeletal Dis. 2025;3:100783
1096 13 1
Open Access Review
Optimizing development of anti-TNFα biosimilars based on 10 years’ experience
Cecil Nick
Published: February 08, 2025 Explor Musculoskeletal Dis. 2025;3:100782
2660 57 0
Open Access Short Communication
Patterns and inequities in pyogenic arthritis-related mortality in the United States from 1999–2020
Usama Qamar ... Eisha Mazhar
Published: January 27, 2025 Explor Musculoskeletal Dis. 2025;3:100781
915 12 0
Open Access Review
Chronic pain, fibromyalgia, and long COVID
Jürgen Braun
Published: January 22, 2025 Explor Musculoskeletal Dis. 2025;3:100780
2261 25 0
Open Access Perspective
Musculoskeletal ultrasound in rheumatologic diseases
Antje L Greenfield, Riti Kanesa-Thasan
Published: January 19, 2025 Explor Musculoskeletal Dis. 2025;3:100779
This article belongs to the special issue Multifaceted Imaging in Rheumatic and Musculoskeletal Diseases
1771 37 0